Transcriptomics

Dataset Information

0

Non-steroidal mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy


ABSTRACT: The objective of this study was to test the novel non-steroidal mineralocorticoid receptor antagonist (MRA) finerenone as a monotherapy in a preclinical Duchenne muscular dystrophy (DMD) model. Microarray was used to detail gene expression differences in ventricular heart tissue from finerenone-treated dystrophin-deficient, utrophin-haploinsufficient Het (utrn+/−; mdx) mice versus untreated Het mice.

ORGANISM(S): Mus musculus

PROVIDER: GSE150302 | GEO | 2020/08/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-11-17 | GSE183840 | GEO
2023-11-17 | GSE183839 | GEO
2023-11-17 | GSE183841 | GEO
2024-04-03 | GSE244569 | GEO
| PRJNA631738 | ENA
2008-06-15 | E-GEOD-7187 | biostudies-arrayexpress
2008-04-23 | GSE7187 | GEO
2007-12-04 | E-GEOD-1463 | biostudies-arrayexpress
2004-12-08 | GSE1463 | GEO
2008-06-15 | E-GEOD-6790 | biostudies-arrayexpress